DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Piperoxan

Piperoxan

  • Tekst

    Tekst

  • United States Patent (19) (11) 4,310,524 Wiech Et Al

    United States Patent (19) (11) 4,310,524 Wiech Et Al

  • Prohibited Substances List

    Prohibited Substances List

  • The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances

    The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances

  • Download Product Insert (PDF)

    Download Product Insert (PDF)

  • Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

    Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

  • 2 12/ 35 74Al

    2 12/ 35 74Al

  • 209089Orig1s000 209090Orig1s000

    209089Orig1s000 209090Orig1s000

  • Panic Attacks During MR Imaging: Treatment with IV Diazepam

    Panic Attacks During MR Imaging: Treatment with IV Diazepam

  • (12) Patent Application Publication (10) Pub. No.: US 2003/0068365A1 Suvanprakorn Et Al

    (12) Patent Application Publication (10) Pub. No.: US 2003/0068365A1 Suvanprakorn Et Al

  • Stembook 2018.Pdf

    Stembook 2018.Pdf

  • A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum

    A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum

  • United States Patent (19) 11 Patent Number: 5,019,591 Gardner Et Al

    United States Patent (19) 11 Patent Number: 5,019,591 Gardner Et Al

  • Histamine, Histamine Receptors, and Their Role in Immunomodulation: an Updated Systematic Review

    Histamine, Histamine Receptors, and Their Role in Immunomodulation: an Updated Systematic Review

  • 2021 Equine Prohibited Substances List

    2021 Equine Prohibited Substances List

  • Index Vol. 16-23

    Index Vol. 16-23

  • Florencio Zaragoza Dörwald Lead Optimization for Medicinal Chemists

    Florencio Zaragoza Dörwald Lead Optimization for Medicinal Chemists

  • United States Patent (10) Patent N0.: US 6,951,860 B2 Mehanna Et A1

    United States Patent (10) Patent N0.: US 6,951,860 B2 Mehanna Et A1

Top View
  • Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
  • Marrakesh Agreement Establishing the World Trade Organization
  • H1 and H2 RECEPTOR ANTAGONIST CONTENTS:  Brief Introduction About Histamine
  • Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
  • 2019 Equine Prohibited Substances List
  • Transdermal Device Containing
  • Noradrenergic Regulation of Serotonergic Neurons in the Dorsal Raphe : Physiological, Pharmacological, and Anatomical Studies Jay Matthew Ab Raban Yale University
  • Pharmaabkommen A1 E
  • Customs Tariff - Schedule Xxi - 1
  • Bioactive Compound Library Plus (96-Well)
  • Harmonized Tariff Schedule of the United States (2005) Annotated for Statistical Reporting Purposes
  • (12) Patent Application Publication (10) Pub. No.: US 2014/0038949 A1 Schultz Et Al
  • 2019 Banned Substances List.Pdf
  • Histamine H1-Receptor Antagonists: Antihistaminic Agents
  • The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
  • “Anxiety” Response in Rhesus Monkeys
  • The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
  • Optimal Prescribing of Drugs to Prevent CVD and Drugs That Cause Dependency: an Evidence Gap Map


© 2024 Docslib.org    Feedback